2023
Mortality of patients with ST-segment-elevation myocardial infarction without standard modifiable risk factors among patients without known coronary artery disease: Age-stratified and sex-related analysis from nationwide readmissions database 2010-2014
Jang S, Kim L, Sobti N, Yeo I, Cheung J, Feldman D, Amin N, Narotsky D, Goyal P, McCullough S, Krishnan U, Zarich S, Wong S, Kim S. Mortality of patients with ST-segment-elevation myocardial infarction without standard modifiable risk factors among patients without known coronary artery disease: Age-stratified and sex-related analysis from nationwide readmissions database 2010-2014. American Journal Of Preventive Cardiology 2023, 14: 100474. PMID: 36923367, PMCID: PMC10009437, DOI: 10.1016/j.ajpc.2023.100474.Peer-Reviewed Original ResearchHospital mortality rateMortality ratePrimary PCIST-segment elevation myocardial infarction (STEMI) patientsStandard modifiable risk factorsAge groupsElevation myocardial infarction patientsModifiable risk factorsNationwide Readmissions DatabaseCoronary artery diseaseMyocardial infarction patientsPost-STEMI patientsOlder age groupsMultivariable adjustmentClinical characteristicsArtery diseaseInfarction patientsRisk factorsWorse outcomesPatientsSTEMIWomenIncreased ratesHospitalOutcomes
2015
GPU-Accelerated Framework for Intracoronary Optical Coherence Tomography Imaging at the Push of a Button
Han M, Kim K, Jang S, Cho H, Bouma B, Oh W, Ryu S. GPU-Accelerated Framework for Intracoronary Optical Coherence Tomography Imaging at the Push of a Button. PLOS ONE 2015, 10: e0124192. PMID: 25880375, PMCID: PMC4400174, DOI: 10.1371/journal.pone.0124192.Peer-Reviewed Original ResearchConceptsOptical coherence tomographyStent strutsCoherence tomographyIntracoronary OCT imagingLong coronary arteryCoronary artery diseaseCause of deathIntracoronary optical coherence tomographyImportant clinical toolRaw OCT dataOCT dataArtery diseaseCoronary arteryGPU-Accelerated FrameworkIntracoronary imagingFD-OCT imagesGraphics processing unitsAccurate diagnosisClinical tool
2011
Fatal Rhabdomyolysis in a Patient with Liver Cirrhosis after Switching from Simvastatin to Fluvastatin
Baek S, Jang S, Park S, Ok T, Leem J, Lee H, Park S, Kim T. Fatal Rhabdomyolysis in a Patient with Liver Cirrhosis after Switching from Simvastatin to Fluvastatin. Journal Of Korean Medical Science 2011, 26: 1634-1637. PMID: 22148003, PMCID: PMC3230026, DOI: 10.3346/jkms.2011.26.12.1634.Peer-Reviewed Original ResearchConceptsFatal rhabdomyolysisLiver cirrhosisContinuous renal replacement therapyAcute renal failureRenal replacement therapyCoronary artery diseaseHMG-CoA reductase inhibitorsSerum creatine kinaseAsymptomatic elevationIntravenous furosemideRenal failureUrine alkalizationArtery diseaseHepatic failureReplacement therapyMassive hydrationRhabdomyolysisPatientsCirrhosisReductase inhibitorsCreatine kinaseAdverse effectsSimvastatinFluvastatinCandesartan